Market Research Report
Ginseng Extracts Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Application (Cosmetics & Personal Care, Pharmaceuticals, Food & Beverages, Dietary Supplements), And Segment Forecasts, 2020 - 2027
|Published by||Grand View Research, Inc.||Product code||952567|
|Published||Content info||150 Pages
Delivery time: 2-3 business days
|Ginseng Extracts Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Application (Cosmetics & Personal Care, Pharmaceuticals, Food & Beverages, Dietary Supplements), And Segment Forecasts, 2020 - 2027|
|Published: July 1, 2020||Content info: 150 Pages||
Market Growth & Trends
The global ginseng extracts market size is projected to reach USD 37.0 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.2% from 2020 to 2027. Growing demand for ginseng extracts in pharmaceutical applications on account of its effectiveness in treating numerous health diseases is likely to enhance market growth over the forecast period.
Significant benefits including potent antioxidants, lowering blood sugar, strengthening the immune system, tackling fatigue, and brain function enhancement, along with improved pharmaceuticals demand, are essential factors for industry expansion.
Ginseng roots are commonly known for their high content of ginsenosides, phenolic, saponins compounds, including carotenoids and carbohydrates. Furthermore, there is a rising awareness regarding the role of ginseng as a functional food or nutraceutical with growing industry value.
Bioactive compounds and extracts isolated from ginseng are utilized for their numerous health-promoting activities, such as antitumor, antioxidant, skin protecting, antihyperglycemic, anticancer, anti-osteoporotic, respiratory, and anti-infective problems.
The pharmaceuticals application segment is projected to witness substantial growth over the forecast period on account of augmented industry opportunities, which is attributed to increasing new product launches by pharmaceutical producers for mitigating rare diseases, along with growing increasing aged population.
The market is highly competitive in terms of product innovation and portfolio expansion. The companies have been proactive in initiating strategies to gain a competitive advantage in the market. In the near term, privately held market participants are expected to follow the suit.